Teen Depression
Research Study
Research Study
Researchers at the University of Minnesota want to know more about brain functioning in teens and young adults with depression. Join our study!
Suicidal Ideation or Behavior
Conducted in Minneapolis, MN
Ages 13-21
Current Diagnosis of Depression
Compensation provided
Fast Facts
| Study Background We want to understand more about what drives self-harming thoughts and behaviors. Negative urgency is the tendency to act impulsively in the context of negative emotion. High levels of negative urgency may place people at increased risk of self-harming thoughts and behaviors. In this study, researchers will examine brain functioning related to negative urgency in teens and young adults with depression and thoughts or behaviors related to self-harm. We are recruiting teens and young adults who have current depression, and who have experienced either suicidal thoughts or behaviors. If you think you or your child might fit this description and be interested in the study, contact the study team today to find out more! Parental permission needed if 17 or younger. |
Additional Information
The goal of this research study is to learn more about brain functioning related to self-harming thoughts and behaviors in teenagers and young adults with depression.
You or your teen may qualify for this study if you meet the following criteria.
Inclusion Criteria:
Inclusion Criteria:
- 13-21 years old
- If you are 18-21, able to provide written informed consent
- If you are under 18, legal guardian is able to provide written informed consent
- Able to communicate in English
- Current diagnosis of a depressive episode
- History of suicidal thoughts
- No prior history of suicidal behavior (a suicide attempt, or a planned attempt that was stopped before it happened)
- Current diagnosis of a depressive episode
- Any history of suicidal behavior (a suicide attempt, or a planned attempt that was stopped before it happened)
- Immediate suicide risk
- Current substance use disorder (besides caffeine or nicotine)
- Lifetime history of psychosis, hypomania, or mania
- Diagnosis of autism spectrum disorder or intellectual disability
- Antiepileptic medication use or chronic benzodiazepine use
- Pregnancy
- Medical or neurologic history that would pose increased risk for transcranial magnetic stimulation (TMS) or magnetic resonance imaging (MRI)
If you are eligible, participation will include the following:
Baseline visit: informed consent; clinical interviews and self-report assessments; computerized behavioral tasks; MRI scan; transcranial magnetic stimulation (TMS) brain function testing; creating a personalized safety plan with help from the study team.
6-Month visit: shorter clinical interviews and self-report assessments; computerized behavioral tasks; TMS testing; reviewing and updating the personalized safety plan.
12-month visit: shorter clinical interviews and self-report assessments; computerized behavioral tasks; TMS testing; reviewing and updating the personalized safety plan.
Baseline visit: informed consent; clinical interviews and self-report assessments; computerized behavioral tasks; MRI scan; transcranial magnetic stimulation (TMS) brain function testing; creating a personalized safety plan with help from the study team.
6-Month visit: shorter clinical interviews and self-report assessments; computerized behavioral tasks; TMS testing; reviewing and updating the personalized safety plan.
12-month visit: shorter clinical interviews and self-report assessments; computerized behavioral tasks; TMS testing; reviewing and updating the personalized safety plan.
Participants will be compensated $300 for completing all study visits.
There is no cost for you to participate in this study.
If you have any questions about this study, please contact us using the information below.
Visit abflab.umn.edu
Email abflab@umn.edu
Call (612) 626-5362
2025 East River Parkway
Minneapolis, MN 55414